Source: NS Medical Devices

Alcresta : Alcresta Therapeutics gets FDA nod for RELiZORB digestive enzyme cartridge

The post Alcresta Therapeutics gets FDA nod for RELiZORB digestive enzyme cartridge appeared first on NS Medical Devices.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Daniel Orlando's photo - Chairman & CEO of Alcresta

Chairman & CEO

Daniel Orlando

CEO Approval Rating

90/100

Read more